Jeffrey Del Carmen sold $696K of Catalyst Pharmaceuticals (CPRX)

Executed Mar 3 2025, disclosed Mar 5 2025, 2 days later.

Value, as filed

$696K

30,423 sh × $22.89

Executed

Mar 3 2025

the trade date, as filed

Disclosed

Mar 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JC Jeffrey Del Carmen Chief Commercial Officer profile →

Jeffrey Del Carmen (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CPRX. The largest single filing was $256K of CPRX (10,983 sh × $23.33, as filed), executed Nov 26 2025.

The name

CPRX CPRX CPRX · 20 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey Del Carmen in CPRX

CPRXSALE CATALYST PHARMACEUTICALS, INC. $256K
10,983 sh × $23.33
Exec Nov 26 2025
Filed Nov 28 2025 · 5:30 PM ET